Literature DB >> 12717694

The impact of the pro- and anti-inflammatory immune response on ventilation time after cardiac surgery.

Markus Rothenburger1, Tonny D T Tjan, Michael Schneider, Elmar Berendes, Christof Schmid, Markus J Wilhelm, Dirk Böcker, Hans Heinrich Scheld, Rasjid Soeparwata.   

Abstract

BACKGROUND: Cardiac surgery using cardiopulmonary bypass (CPB) may induce a systemic inflammatory response syndrome (SIRS), which is associated with an increased risk of postoperative morbidity and mortality. The intention of this pilot study was to investigate the influence of the pro- and anti-inflammatory cytokine responses as well as of released adhesion molecules and endotoxin on the time requirements for assisted postoperative respiration following CPB surgery.
METHODS: One hundred consecutive patients undergoing elective coronary artery bypass grafting (CABG) using CPB were prospectively investigated. Blood levels of cytokines, adhesion molecules, and endotoxins were serially measured at four time points perioperatively.
RESULTS: All patients survived the observation period. Eighty-five patients were uneventful (group 1), whereas 15 patients required prolonged ventilation (34.8 +/- 9.2 h; group 2). All patients developed a pro-inflammatory and a compensatory anti-inflammatory cytokine response. An endotoxin liberation was found in parallel. The prediction of prolonged respirator dependence may be possible at completion of surgery using a combined data pattern analysis, including interleukin (IL)-6, IL-8, IL-4, endotoxins, vascular cell adhesion molecule (VCAM)-1, age, and cross clamp (x-clamp) time. Using arbitrary cutoff points improved sensitivity (0.92), specificity (0.90), positive prediction (0.87), and negative prediction (0.85) (all P < 0.02), and the ODD ratio (2.1) was found.
CONCLUSIONS: Cardiac surgery and CPB induces both a pro- and anti-inflammatory immune response. The use of a data pattern instead of several individual parameters seems advantageous for individualized predictions on postoperative recovery in CPB surgery. Copyright 2003 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12717694     DOI: 10.1002/cyto.b.10027

Source DB:  PubMed          Journal:  Cytometry B Clin Cytom        ISSN: 1552-4949            Impact factor:   3.058


  6 in total

1.  On-pump beating heart versus conventional on-pump coronary artery bypass grafting on clinical outcomes: a meta-analysis.

Authors:  Chen Wang; Yefan Jiang; Xionggang Jiang; Si Chen
Journal:  J Thorac Dis       Date:  2021-07       Impact factor: 2.895

Review 2.  Hsp70 and cardiac surgery: molecular chaperone and inflammatory regulator with compartmentalized effects.

Authors:  Petrus R de Jong; Alvin W L Schadenberg; Nicolaas J G Jansen; Berent J Prakken
Journal:  Cell Stress Chaperones       Date:  2008-07-31       Impact factor: 3.667

3.  Interleukin-8 and acute kidney injury following cardiopulmonary bypass: a prospective cohort study.

Authors:  Orfeas Liangos; Alexey Kolyada; Hocine Tighiouart; Mary C Perianayagam; Ron Wald; Bertrand L Jaber
Journal:  Nephron Clin Pract       Date:  2009-08-12

4.  Use of Therapeutic Plasma Exchange during Extracorporeal Life Support in Critically Ill Cardiac Children with Thrombocytopenia-Associated Multi-Organ Failure.

Authors:  Mei Chong; Alejandro J Lopez-Magallon; Lucas Saenz; Mahesh S Sharma; Andrew D Althouse; Victor O Morell; Ricardo Munoz
Journal:  Front Pediatr       Date:  2017-12-01       Impact factor: 3.418

5.  Off-pump or on-pump coronary artery bypass at 30 days: A propensity matched analysis.

Authors:  Chen Wang; Yefan Jiang; Yu Song; Qingpeng Wang; Rui Tian; Dashuai Wang; Nianguo Dong; Xionggang Jiang; Si Chen; Xinzhong Chen
Journal:  Front Cardiovasc Med       Date:  2022-08-01

6.  Early and Long-Term Outcomes after On-Pump and Off-Pump Coronary-Artery Bypass Grafting in Patients with Severe Left Ventricular Dysfunction and a Giant Left Ventricle.

Authors:  Chen Wang; Yefan Jiang; Qingpeng Wang; Rui Tian; Dashuai Wang; Xionggang Jiang; Nianguo Dong; Si Chen; Xinzhong Chen
Journal:  J Cardiovasc Dev Dis       Date:  2022-09-06
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.